A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.

Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer.

Prostate cancer is the leading cancer among Kenyan men, with an estimated 3,582 men being diagnosed with the disease at some ...

Prostate cancer is the most commonly diagnosed cancer in the UK. But screening is not universal, and charities are divided over whether it should be extended. What do those living with the disease ...

Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following ...

A world-first trial of Australian men has confirmed a specialised scan can accurately “light up” prostate cancer, saving ...

Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and will never cause harm.

A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...

Ricky Gervais' longtime partner Jane Fallon shared that she had been diagnosed with breast cancer earlier this year, but was ...

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...